CN101143170B - Traditional Chinese medicine composition for treating rectum cancer - Google Patents
Traditional Chinese medicine composition for treating rectum cancer Download PDFInfo
- Publication number
- CN101143170B CN101143170B CN200610104558XA CN200610104558A CN101143170B CN 101143170 B CN101143170 B CN 101143170B CN 200610104558X A CN200610104558X A CN 200610104558XA CN 200610104558 A CN200610104558 A CN 200610104558A CN 101143170 B CN101143170 B CN 101143170B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- rectum cancer
- remedying
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicine and concretely relates to a combination of traditional Chinese medicine for remedying the rectum cancer. The invention provides a combination of traditional Chinese medicine for remedying the rectum cancer to conquer the problem of the prior art of no effective drug for remedying the rectum cancer. A technical proposal of the invention is a combination of traditional Chinese medicine for remedying the rectum cancer, which is prepared by a ginseng, an angelica, a glossy ganoderma, a rosin, an orange fruit, a dahurain angelica root, a Szechwan lovage rhizome, a cassia twig, a white bark of Japanese pagoda tree root, a lightyellow sophora root, a cow-bezoar, a snow lotus, a muskiness, a pangolin scale, a Chinese honeylocust spine and a hedgehog skin with the equivalent quantity. The combination of traditional Chinese medicine has the advantages of good curative effect, safe and reliable pure traditional Chinese medicinal preparation, being easily for the patient to accept the treatment etc.
Description
Affiliated technical field:
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the treatment of rectal cancer.
Background technology:
Rectal cancer is a kind of special disease that directly causes the people in the fatal position.The cardinal symptom of rectal cancer patient shows as bowel habit in early days mostly and changes, and increased frequency always has row's sensation not to the utmost, and tenesmus constipation occurs, has blood in stool.Further develop symptoms such as stool becomes flat, attenuates, abdominal distention, borborygmus, stomachache to occur.Serious caused intestinal obstruction and symptoms such as swift pulse, fever, abdominal distention stomachache, singultus, vomiting occur.
From ancient times to the present, medical worker from name of disease symptom, etiology and pathogenesis, has carried out various demonstrations with regard to this disease, and the ancient book kind claims that this disease is a dysentery.The main pathogenic factor of rectal cancer, ancient medicine are thought " the dysentery person accumulates long-pending poison and begins disorderly for a long time ".
At present, still there is not effective method both at home and abroad and medicine is used for the treatment of rectal cancer.Usually used Therapeutic Method is the method for doctor trained in Western medicine excision, but the life-span of most patient with operation can only delay less than year, the patient with operation that lives through 3 years is few.Drug therapy does not then have alternative effective kind.Therefore, up to the present, rectal cancer is still the forbidden zone of harm humans life.
Summary of the invention:
The present invention will provide a kind of Chinese medicine composition for the treatment of rectal cancer, effectively treats the problem of the medicine of rectal cancer to overcome nothing that prior art exists.
For overcoming the problem that prior art exists, technical scheme of the present invention is: a kind of Chinese medicine composition for the treatment of rectal cancer is that raw material Radix Ginseng, Radix Angelicae Sinensis, Ganoderma, Colophonium, Fructus Aurantii, the Radix Angelicae Dahuricae, Rhizoma Chuanxiong, the Ramulus Cinnamomi by equivalent is prepared from.
Above-mentioned raw materials also comprises Cortex sophorae, Radix Sophorae Flavescentis, Calculus Bovis, the Herba Saussureae Involueratae of equivalent.
Above-mentioned raw materials also comprises Moschus, Squama Manis, Fructus Gleditsia, the Corium Erinacei Seu Hemiechianus of equivalent.
Above-mentioned raw materials is made powder through grinding.Result of use is better.
For many years to patient's etiology and pathology analysis, find that the occurrence cause one of rectal cancer is an exopathogenic factor through us, be subjected to damp and hot for a long time and the formation of making a bet; The 2nd, polyp hemorrhoid generation pathological changes forms, and divides chronic and acute two kinds, and acute made patient is difficult to Ambulatory Activity in a week, agonizing, rapidly threat to life.The later stage rectum of pathological changes narrows down, torsional deformation, and sclerosis is as stone.Therefore present medicine with other treatment cancer is treated rectal cancer and is tantamount to throw an egg against a rock, and has no effect.
Through clinical treatment for many years, the inventor has carried out the research practice of various pathology pharmacology to rectal cancer, and the Chinese medicinal formulae of present effective treatment rectal cancer of developing has and fills blood, the meridian dredging, heat-clearing and toxic substances removing, reducing swelling and alleviating pain, decomposes the effect of eliminating focus fully.The side separates as follows: Radix Ginseng, Radix Angelicae Sinensis, Ganoderma are monarch drug, blood yiqi altogether; Colophonium, Fructus Aurantii, the Radix Angelicae Dahuricae, Rhizoma Chuanxiong, Ramulus Cinnamomi are ministerial drug altogether, the pain relieving of circulation of qi promoting removing toxic substances; Cortex sophorae, Radix Sophorae Flavescentis, Calculus Bovis, Herba Saussureae Involueratae clearing away heat and cooling blood; Moschus, Squama Manis, Fructus Gleditsia, Corium Erinacei Seu Hemiechianus aid yang qi, the meridian dredging.
Modern medicine proves that host immune function lowly is the topmost intrinsic factor that cause cancer, adjusts immunologic function, and it is played a role, and just can effectively control and breaks up cancerous cell, reaches the purpose of effective treatment.The present invention is in the process of treatment tumor, adopt the method for " attack, disappear, loose, mend ", when tumor is dissolved in control, improve the healthy energy of human body, promote QI-blood circulation, function is adjusted to optimum state, resist exopathogen, make the state of an illness controlled, focus is progressively dwindled, and reaches the purpose of treatment.Can also prophylacticly further develop simultaneously, stop the transfer of focus.Because the present invention defers to the tradition that the traditional Chinese medical science is paid attention to adjustment and escorted the human righteousness, therefore aspect treatment, demonstrate unique effect.
Compared with prior art, this medicament proves to have following advantage through clinical application for many years:
1. therapeutic effect is good: can take effect a general course of treatment of patient (three days), has white pus or yellow pus to efflux with stool, swollen, bloated, painful sx or disappearance, and this moment, rectum carcinoma body began differentiation, and focus is tentatively controlled; After finish five courses of treatment, make the tumor body be contracted to 1/3rd to 1/5th; Complete obiteration after one month, patient can normal activity work.For patient age is below 65 years old, morbidity just, operation, shift, under the UF situation, therapeutic effect is better, take effect a course of treatment, can fully recover behind the first quarter moon.
2. pure Chinese medicinal preparation, safe and reliable: the present invention is nontoxic to human body, and is safe and reliable, without any side effects; Treatment is not recurred after finishing, and does not rebound, and does not have any sequela.
3. being easy to the patient receives treatment: simple and convenient, and do not operate on, be not in hospital, expense is low, the patient is acceptant.
The specific embodiment:
Below in conjunction with specific embodiment the present invention is described in detail.
Embodiment 1: a kind of Chinese medicine composition for the treatment of rectal cancer is prepared from by Radix Ginseng 10g, Radix Angelicae Sinensis 10g, Ganoderma 10g, Colophonium 10g, Fructus Aurantii 10g, Radix Angelicae Dahuricae 10g, Rhizoma Chuanxiong 10g, Ramulus Cinnamomi 10g.
Embodiment 2: a kind of Chinese medicine composition for the treatment of rectal cancer is prepared from by Radix Ginseng 10g, Radix Angelicae Sinensis 10g, Ganoderma 10g, Colophonium 10g, Fructus Aurantii 10g, Radix Angelicae Dahuricae 10g, Rhizoma Chuanxiong 10g, Ramulus Cinnamomi 10g, Cortex sophorae 10g, Radix Sophorae Flavescentis 10g, Calculus Bovis 10g, Herba Saussureae Involueratae 10g.
Embodiment 3: a kind of Chinese medicine composition for the treatment of rectal cancer, and by Radix Ginseng 10g, Radix Angelicae Sinensis 10g; Calculus Bovis 10g, Moschus 10g, Ganoderma 10g; Fructus Gleditsia 10g, Fructus Aurantii 10g, Cortex sophorae 10g; Corium Erinacei Seu Hemiechianus 10g, Radix Sophorae Flavescentis 10g, Rhizoma Chuanxiong 10g; Herba Saussureae Involueratae 10g, Radix Angelicae Dahuricae 10g, Ramulus Cinnamomi 10g; Colophonium 10g, Squama Manis 10g is prepared from.
In the foregoing description, be most preferred embodiment with embodiment 3.
Each equal portions raw material of Chinese medicine composition of the present invention is processed as powder through grinding, and be three days each course of treatment.。Its using method is: divide every day by the dosage of embodiment and take for 3 times, each 5-6 gram is mixed well for oral administration by former Mel.Be coated with at the disease sites body surface simultaneously and use medicine for external use, this medicine for external use is powder medicine 30 grams with processing, is in harmonious proportion with thick ink 100 grams, per hour once, is coated on the focus body surface.
Taboo: this medicament oral and external application medicine is forbidden the anemia of pregnant woman, and medicine for external use must not be oral.
Chinese medicine composition of the present invention is made use by oneself for many years through the inventor, and the patient of treatment is an object with the outpatient that grows up, and patient age 20～70 years old all through clinical means such as CT examination, section, chemical examination, enteroscopies, is made a definite diagnosis disease.Now putting 50 routine rectal cancer cases in order is added up, in arrangement, adopt self treatment front and back symptom contrast, press cancer therapy drug clinical research guideline entity, objective efficacy assessment standard evaluation observed result, in therapeutic process, use the Chinese medicine of embodiment 3 to treat:
Clinical cure: the positive Signs of symptom and inspection disappears, diet, and spirit, every vital sign such as blood pressure recovers normal, and recovers certain work capacity.
Produce effects: after curing five courses of treatment, symptom disappears substantially, and focus is dwindled, and every index of physical examination all take a favorable turn.
Effectively: symptom is improved fully, and focus is eliminated substantially.
Through observing: the most patients symptom obviously alleviates or disappears taking medicine after, and appetite increases, spiritual improvement, and quality of life is improved, and part patient observes the tumor body and dwindles.Obvious effective rate is 15% by statistics, and effective percentage is 80%, and total effective rate is 95%.
This Chinese medicine composition oral administration and externally plays and attacks within and outside, and the effect of yin yang complementarity reaches the purpose for the treatment of both the principal and secondary aspects of a disease.
Claims (2)
1. a Chinese medicine composition for the treatment of rectal cancer is characterized in that being prepared from by raw material Radix Ginseng, Radix Angelicae Sinensis, Ganoderma, Colophonium, Fructus Aurantii, the Radix Angelicae Dahuricae, Rhizoma Chuanxiong, Ramulus Cinnamomi, Cortex sophorae, Radix Sophorae Flavescentis, Calculus Bovis, Herba Saussureae Involueratae, Moschus, Squama Manis, Fructus Gleditsia, the Corium Erinacei Seu Hemiechianus of equivalent.
2. a kind of Chinese medicine composition for the treatment of rectal cancer according to claim 1 is characterized in that each raw material makes powder through grinding.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610104558XA CN101143170B (en) | 2006-09-12 | 2006-09-12 | Traditional Chinese medicine composition for treating rectum cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610104558XA CN101143170B (en) | 2006-09-12 | 2006-09-12 | Traditional Chinese medicine composition for treating rectum cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101143170A CN101143170A (en) | 2008-03-19 |
| CN101143170B true CN101143170B (en) | 2010-08-25 |
Family
ID=39206025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200610104558XA Expired - Fee Related CN101143170B (en) | 2006-09-12 | 2006-09-12 | Traditional Chinese medicine composition for treating rectum cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101143170B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101785847A (en) * | 2010-02-28 | 2010-07-28 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine combination for intestinal caner treatment and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1185956A (en) * | 1996-12-23 | 1998-07-01 | 周德 | A cancer medicine |
| CN1399979A (en) * | 2001-07-30 | 2003-03-05 | 张官锁 | Chinese medicine composition for curing cancers |
| CN1442159A (en) * | 2002-03-05 | 2003-09-17 | 张少华 | Traditional Chinese medicine for treating cancer and its preparation method |
-
2006
- 2006-09-12 CN CN200610104558XA patent/CN101143170B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1185956A (en) * | 1996-12-23 | 1998-07-01 | 周德 | A cancer medicine |
| CN1399979A (en) * | 2001-07-30 | 2003-03-05 | 张官锁 | Chinese medicine composition for curing cancers |
| CN1442159A (en) * | 2002-03-05 | 2003-09-17 | 张少华 | Traditional Chinese medicine for treating cancer and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101143170A (en) | 2008-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703692A (en) | Chinese medicinal preparation for treating bone fracture and preparation method thereof | |
| CN105535694A (en) | Traditional Chinese medicine composition for treating hyperuricemia | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN101406535B (en) | Chinese medicinal decoction for treating urinary lithiasis | |
| CN102697934A (en) | Golden cypress traditional Chinese medicine preparation for treating diarrhea and preparation method for preparation | |
| CN101091769B (en) | Medicine for treating and preventing esophagus cancer and gastric cancer, and preparation method | |
| CN104069162B (en) | A kind of Chinese medicine for treating urarthritis and various bone joint pains | |
| CN102626508B (en) | Traditional Chinese medicine composite for curing liver cancer | |
| CN101007159B (en) | Traditional Chinese medicine for preventing and controlling tumor | |
| CN102940815A (en) | Medicine prescription for treating tuberculosis and tuberculous rheumatism | |
| CN101143170B (en) | Traditional Chinese medicine composition for treating rectum cancer | |
| CN102698024B (en) | Oral traditional Chinese medicine preparation for treating postoperative intestinal adhesion | |
| CN102698130B (en) | Traditional Chinese medicine extract for treating postoperative intestinal adhesion | |
| CN100349587C (en) | Medicine for treating acute and chronic pancreatitis | |
| CN102872362A (en) | Traditional Chinese medicine for treating chronic cholecystitis | |
| CN104800675A (en) | Medicament for treating active ulcerative colitis | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN104740540A (en) | Heat-clearing and detoxifying preparation for treating appendicitis | |
| CN103977276A (en) | Traditional Chinese medicine capsule used for treating radiocystitis | |
| CN102805795B (en) | Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof | |
| CN102698129B (en) | Traditional Chinese medicine composition for treating postoperative intestinal adhesion | |
| CN101190289B (en) | Traditional Chinese medicine for treating combined hemorrhoid postoperative edema pain | |
| CN106138686A (en) | Traditional Chinese medicine preparation for treating early-stage goiter | |
| CN117122661A (en) | Traditional Chinese medicine composition and preparation for treating chronic cholecystitis liver Yu Dan heat syndrome and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100825 Termination date: 20110912 |